CD8A and pancreatic adenocarcinoma: In patients with gastrointestinal (GI) tumors, infiltration of CD3+ T cells is associated with a higher rate of progression free survival [5], and pancreatic adenocarcinomas containing both CD4+ and CD8+ T cells correlated with an improved prognosis and significantly greater 5-year survival for these patients [6–8].